Companies / BOC Sciences / Tiragolumab
BOC Sciences

Tiragolumab | BOC Sciences

Tiragolumab is a humanized monoclonal antibody and immune checkpoint inhibitor that selectively binds to TIGIT, which suppresses the immune response to cancer.

Reviews


No reviews yet

ABOUT THE COMPANY

BOC Sciences specializes in small molecule synthesis, biosynthesis, purification, and characterization. It provides a wide range of research chemicals and biochemicals, including inhibitors, building blocks, carbohydrates, nucleosides, nucleotides, GMP Products, impurities and metabolites, APIs, natural compounds, ADCs, stem cell molecules and chiral compounds.
  • See More